{
    "title": "J&J, AbbVie cancer drug significantly slows progression of rare lymphoma -study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10881931/J-J-AbbVie-cancer-drug-significantly-slows-progression-rare-lymphoma-study.html",
    "date": "2022-06-03",
    "keywords": [
        "drug",
        "treatment",
        "mcl",
        "lymphoma",
        "study",
        "erman",
        "type",
        "asco",
        "june",
        "johnson",
        "imbruvica",
        "combination",
        "check",
        "mantle",
        "cell",
        "placebo",
        "regimen",
        "bendamustine",
        "ibrutinib",
        "disease",
        "measure",
        "survival",
        "pfs",
        "chemotherapy",
        "trial",
        "society",
        "oncology",
        "meeting",
        "chicago",
        "dr",
        "julie",
        "gralow",
        "officer",
        "practice",
        "increase",
        "patient",
        "incidence",
        "case",
        "year",
        "leukemia",
        "cll",
        "therapy",
        "march",
        "jampj",
        "approval",
        "europe",
        "data",
        "company",
        "use",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}